ARTELO BIOSCIENCES, INC. Cash Equivalents, at Carrying Value
ARTELO BIOSCIENCES, INC. (ARTL) had Cash Equivalents, at Carrying Value of $1.72 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2025-11-12
- 2025-09-30: Cash Equivalents, at Carrying Value $1.72M.
- 2025-06-12: Cash Equivalents, at Carrying Value $2.07M.
- 2025-03-31: Cash Equivalents, at Carrying Value $700.00K.
- 2022-09-30: Cash Equivalents, at Carrying Value $7.14K.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-09-30 | $1.72M 10-Q · filed 2025-11-12 | |
| 2025-06-12 | $2.07M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $700.00K 8-K · filed 2025-07-11 | |
| 2022-09-30 | $7.14K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $12.10M 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $12.16K 10-Q · filed 2022-11-08 | $12.20M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |